Pictet Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151M | Sell |
464,606
-16,361
| -3% | -$5.32M | 0.15% | 158 |
|
|
2025
Q1 | $130M | Buy |
480,967
+50,355
| +12% | +$13.6M | 0.14% | 167 |
|
|
2024
Q4 | $101M | Sell |
430,612
-234,110
| -35% | -$55.1M | 0.11% | 202 |
|
|
2024
Q3 | $183M | Sell |
664,722
-93,806
| -12% | -$25.8M | 0.2% | 132 |
|
|
2024
Q2 | $184M | Sell |
758,528
-202,976
| -21% | -$49.3M | 0.21% | 116 |
|
|
2024
Q1 | $145M | Buy |
961,504
+75,919
| +9% | +$11.4M | 0.16% | 168 |
|
|
2023
Q4 | $170M | Buy |
885,585
+94,830
| +12% | +$18.2M | 0.19% | 138 |
|
|
2023
Q3 | $140M | Buy |
+790,755
| New | +$140M | 0.17% | 158 |
|